this, guys. he sounds very upbeechlt his doctors have given him a very upbeat diagnosis for what's going on. he said that this was as if he was in northerlial excellent health. his energy level is stel 100%. he plans to take on a course of radiation treatment. the timing of the two-month treatment by pushing it off to mid-july, it was chosen to keep from interfering with previous commitments already made. he's investigate a lot of things coming including the sun valley retreat that happens in early july. after that he wouldn't have to worry about things on the books he'd have to cancel. he wants to keep his commitments to giving pledge and other thing. he says his doctors have no qualms about delaying treatment. they said they wouldn't have minded if he pushed it off to october or later than that. in his letter he released earlier this year, he said the board has chosen his successful. he said that person does not know that they are chosen. yesterday he said there's been no change in the succession plan and that potential successor is still unaware that he is the person. >> did hee talk about why he was going to pursue radiation? one of the things i've been reading about is many people at this age, actually not at this age, many stages but stage 1, it's a watch and wait. >> we've read all kinds of things in the general news about whether you do anything, about how many men as they age are likely at some point to get prostate cancer, one out of three, and you heard sometimes at a certain age if you don't do anything, it doesn't really affect -- if you're 82 years, you wouldn't see an effect for 10 years or so. >> they don't even recommend a psa test over the age of 75. >> yesterday what i saw was fascinating. it was a taillight. it was from the "new york post." it said something about an ultrasound that treats it. >> i read a little about it too. >> we know so many people. arnie, the king, he's done well, giuliani, right. >> we've seen a lot of people choose different ways which don't know as much as this guy does. joining us now, joining us now into prostate cancer and especially stage one. he's been name add top dodge tore by u.s. news and world report. he chairs nyu's department of urology. thank you for joining us. you've heard a lot of comment knowledge comments that we've just given that we've read in the general meet ya. it is good to have you here to clear some of this up. do most men for whatever reason if you live long enough, does that become an issue? is that true? >> it's pleasure to be here. first of all, in terms of the prevalence of prostate cancer, about one in ten men will be diagnosed with prostate cancer during they've lifetime. i think one myth we have to be a little bit concerned about, and that is that prostate cancer is the sort of innocuous malignancy. what we have to realize is this is the second most common cause of cancer deaths in men. so while no doubt some men will be diagnosed with slow growing prostate cancers and if their life expectancy is within five to ten years, those slow growing prostate cancers will not be a problem and a watchful wait and active surveillance would be ide ideal. you know what? when they say stage 1, what that simply means is on the digital rectal examination, you did not feel a hard spot on the prostate. but you can have a very aggressive cancer that's diagnosed because of an elevated psa, thabd can be a life-threatening cancer for even men with five-year life expectancies. so just because we hear that warren buffett had stage 1, we can't imply that this is necessarily and may even pose a threat for a very healthy 81-year-old man. >> doctor, one of the things you mentioned. in cancer statistics, you look at average life years lost. there are some cancers that come on much later in life that are not as -- that's all tragic obviously, but leukemia affecting chirp or people in their 30s. if you -- where would prostate be in that sense? it wouldn't be necessarily number two. it's usually elderly people, right? >> not necessarily. >> really. it can be young, okay. >> yeah. the average person. i'm a pros at the cancer doctor. on the thousands of men i performed a radical prosectomy, 57, 58. there are no doubt men who die of prostate cancer, one, it's a miserable death and it's one that at any age you'd want to avoid. >> yeah. >> you know, doctor, i was going to ask you in term os testify radiation treatment that mr. buffett's going to go through, what that's going to be like, how that's going to affect his day to day. >> well, you know, he hasn't really disclosed -- i don't know all the details. it sounds like, you know, there's different options. one could have the seeds implanted. these radioactive seeds. that's really a simple outpatient procedure. he will come in about five days a week for six to eight weeks and during the course of his treatment, he'll be able to resume his regular, what i'm sure is a very busy and active day. may feel a little tired. i mean some of the side effects that he may encounter are typically the bowel symptoms, frequency with bowel movements and urinary frequency and erectile dysfunction. i think for the most part, if this information wasn't made public, he might even be able to carry on his day without the fanfare. >> yeah. >> that's being -- that his diagnosis is being met with. >> this is all -- we're revi reviewing it in the prism of him being the greatest living investor and it's about succession and about what berkshire that you would rnlt normally start immediately asking these questions, but we do -- in this case, the average life expectancy for someone who's 81 years old, is it true that once you make it to 81, you've got like nine -- i'm trying? you've about got about nine more or even ten. >> which is awesome. >> and it's great. it's great to the great medical advances we've made. does this change that? is it no longer nine or ten years with someone with stage 1 prostate cancer? >> again. let me clarify. he can have a stage 1 cancer. the way we grade or assess the aggressiveness of a cancer is, one, on the digital wreck tile exam dirkd we feel a hard spot that's gone outside of the prostate and we have a greasen score that's under the microscope. sfen, you can have a stage 1 cancer vrks a gleason 9, which is very, very aggressive, which has a very high possibility of threatening the well being of even someone who is 81 years of able. so we know it's stage 1, but that doesn't give us the complete picture of how aggressive is this cancer. >> okay. >> there's a recent study that showed that if you have sort of intermediate grade cancer and you undergo radical techniques which is another way to cure prostate cancer versus no treatment, and this was done in scandinavia, that for those cancers, by the time you have a ten-year time period, you do see an increase in survival. so presumably with mr. buffett, 81, we dodge know his status, but if it's stage 1, there's a good probability. it's not just dying of the saner is. you know, you could then develop metastases that spreads to the bones. you have various treatments. and you can have a great deal of problems during your lifetime without actually dying of the disease. >> yeah. the quality of life. >> and that's what one would also try to avoid by intervening. >> yep, yep. >> doctor, just to caution our viewers and in the context of what mr. buffett said yesterday, he did say he believed there wasn't life tletzenning and his doctor doesn't believe it's remotely life-threatening. in this cop text -- >> and that he easing till july for treatments. >> you wouldn't imagine that even though it's stage 1, it would be one of these more severe versions that you discussed, right? >> if it's not life-threaten, why would one intervene to treat? i think wait means is there's no imminent threat. it's like a lung cancer or pan cree alt ilk cancer where that diagnosis is going to lead to a mortality within a year or two. i think the reason why he's elected treatment is he views his life expectancy at 10 years or beyond and he doesn't want to die of cancer at 92 or 95. i think the indication is over the short or intermedial horizon, if he did not pursue treatment, then heouldive his life normally. he's invested in the future and now he's investing in his future by intervening at this time point. >> thank you, doctor, for taking the time with us this morning. i appreciate it. >> my pleasure. >> okay joobd warren buffett's health announcement, of course, puts a lot of focus on berkshire's investment planning. good morning to you, jeff. >> good morning, andrew. >> i imagine -- i hope you had an opportunity to hear what the doctor said. i'm curious in that context whether you think from a corporate government's perspective it was necessary for mr. buffett to come forward with this news. >> i think it's a great model. it is a disease that can be life-threatening. of course, any surgical intervention is risky in itself and perhaps even a noncosmetic minor surgery should be revealed certainly to the board. to the shareholders, who in contrast, of course, steve jobs who was a genius vilgsa avision so many was a misfailing to actively lead investors about the subject of his health. buffett sharing the information. yes, it's appropriate. a ceo like the rest of us would like provecy but you surrender that when you take on the role in paub lick company. it was interesting to note in a success front, this is a company's board where the average age is high in the 70s. rren buffett is by far not the oldest on the board. he's the fourth young oeflt or fifthi youngesioyoungest. >> jeff, you know, we're about three weeks away from berkshire's annual meeting. of course, succession always an issue. what would you want in sort of the corporate practice, good practices, best practices, what would you want to hear from him this year. >> you'd like a sense that the names that have been discussed where it's likely to be -- you'll hear this name. the b the berkshire girl ruru from ti time, theory so critical of the business they would stay if one of the others are selected. there are companies where you have rival warlords where you see an exodus when the failing -- the other candidates don't get the position. since there's only one warren buffett, we'd like to see -- if that whole team stayed in support for tim cooke. lieu hock mu it is soar. we'd like to see when we have another genius that won't be was together that the team will stay intact. we don't have those reassurances yet. dhienlts have to tell white house the final choice would be but in some sense there's a great deal of respect for them. >> jeff, i'm going to ask what sounds like an awful question. how critical is warren buffett? i ask him in the contest that he's trying to create a business, con glom wrat of businesses that can literally on rate themselves without him. >> that's a have interesting question. you an some of it himself. he wish head texed the tex tooil company. he wound up buying the guy out, firing him and he found several hundred value if he had sold it sooner. whether or not it was us airways or coke which was down for a while or solomon brothers, he takes the personal blame for some of these. maybe it's just his generosity of spirit but he hanls been infallib infallible. you know, neither have his lieutenants. he has people who have the courage too challenge him. munger, i believe, is a visa chairman, 89 years old, i believe. he can tell true to power. this is a teal. no matter what age you are, you have the peer gauging. i think that's remarkable. at the same retreat buffett was asking about retreat plans and murdock says i don't have any intentions go anywhere. buffett said i heard of managing outside the box bgs, but that's the extreme. >> jeff son enfelt, coming up. we've got earnings action. we've got a tech names. our news makers of the hour. they're going to be on our show. steend. rage just crossed above the 20. tdd# 1-800-345-2550 we're hitting new highs. tdd# 1-800-345-2550 the spx is on my radar. tdd# 1-800-345-2550 and i'm on top of it all with charles schwab. tdd# 1-800-345-2550 tdd# 1-800-345-2550 i use streetsmart edge and its tools like... tdd# 1-800-345-2550 screener plus. tdd# 1-800-345-2550 i can custom build my own screens tdd# 1-800-345-2550 or use predefined ones to help me find tdd# 1-800-345-2550 possible trading opportunities quickly. tdd# 1-800-345-2550 i can also bounce my ideas off their trading specialists - tdd# 1-800-345-2550 on the phone or face-to-face. tdd# 1-800-345-2550 and i can trade wherever i want, whenever i want. tdd# 1-800-345-2550 tdd# 1-800-345-2550 the kicker? tdd# 1-800-345-2550 i pay $8.95 a trade. tdd# 1-800-345-2550 that's a deal in any language. tdd# 1-800-345-2550 hey... a breakout on a head and shoulders bottom! tdd# 1-800-345-2550 that's what i'm talking about. tdd# 1-800-345-2550 open an account and trade up tdd# 1-800-345-2550 to 6 months commission-free. tdd# 1-800-345-2550 call 1-866-222-5638 tdd# 1-800-345-2550 and start trading today. welcome back. a multibillion-dollar takeover deal just moments ago. >> did you not break this? what about deal book? i thought you were breaking this news. i thought you were working -- >> i worked all weekend on this. this is your thing. don't start putting it on me every time you miss one. sxc health solutions. how many are on your staff at deal book? >> i rely on you, jim. >> oh, my gosh. this wasn't on anyone's radar? >> i thought you would have had this one. >> it would have helped if i had heard of sxc health solutions. it's worth $4.4 billion. the transactions cat lilt at 28%, above tuesday's close. both companies specialize in pharmacy, benefit, management tools. oh, okay. >> the first ever intel-chip-based cell phones shipped this week. coming after the announcement that their first quarter results beat the street. stacy smith was on yesterday. >> we saw strong growth in emerging markets and that was offsaidset by relative invuftmentes? and craig becker, semiconductor analyst joins us. what was the thick that jumped out at you? is there a problem there? >> they guided to margins, which is about a point lower than the street was. >> these why it's up at 28 all of a sudden because margins have within really strong. >> they brought back a ton of stock over the last four to six quarters. they have a lot less net cash because they've reduced 20% of the share count so, that's really helped. the gross margin thing is pretty much a bump in the road. >> over the last two or three years we made the point at 22 or 23 the company would have a great quarter and sell off again. it finally got through at the same time that we were hearing that ipads were replacing pcs and it should hurt intel. it's always counterintuitive. >> they bought back a ton of stock. >> really. that's why. >> so that still imbeds a lot of fear about smartphones hitting pc unit growth and tablets hitting pc unite growth, so the fear is still out there. there's not as much fear baked in. that sarksd smartphones and tablets are still impacting pc unit growth rate. if you want to own a meg ta chip growth maker, i prefer qualcomm. they're the intel of the global world so to speak. and company. they're benefiting from 3g, 4g strength while intel is growing while you have the tablets eating up the market share. >> what did you learn more on the fact whether people are buying pcs or laptops. >> people are. the market researchers revised key one to be up 1% year ore year. so maybe pc consumption is a little bit better than 1% year over year. the notebook market is still growing but not growing terribly fast. >> in the intro to you, we talked about intel making some inroads into smartphone chips. can they do it in smartphones? can they do it in tablets? >> well, they're really trying. they may try out intel chips in a phone or two. you know. what kind of -- assessment. these aren't mainstream. intel is coming in with their ultra books. they do have some advantages. they're trying to leverage those advantages and make it imtell-based tablets and ultra books and hybrid form factors with touchscreens. so those touch-screened based notebooks are coming late this year. so that could get some people excited. hopefully that spurs the market a little bit. great. >> in 1995 hi was diagnosed. he's still going strong. >> he is. he lectures at sanford these days. >> did he undergo treatment? >> yes, yes. >> it was early. caught early. >> right. >> intel is doing a lot. it doesn't get as much attention but they definitely are powering next generation telk knollgy there. >> is there a growth platform for that. do you thing that will become a part of the bigger numbers down the road? >> it's hard to say. it's kind of lumping into an all other bucket. >> i wonder what kind of treatment they had at the time. it's 2012. thank you craig berger. appreciate it. >> thank you. >> in ore tech news, yahoo!'s first quarterly numbers beating the street. portfolio manager of the jacob internet fund. 5% of the fund is in yahoo! shares and good morning to you. >> good morning to you. >> this was a good number. and surprised a lot of people. i must say, including myself. what was the big surprise for you? >> well, thank they showed revenue growth. i think that, you know, that is something that hasn't happened for quite some time. it's very minimal revenue growth so no one's throwing a big party. . given that the vast majority of yahoo! lies within their shane assets, whatever they can do only means core business. >> was there anything on the call with scott thompson the new ceo about the issue, what they're going to do with the alibaba and the structure going forward that gave you confidence or frankly undermining that confidence? >> no. actually it was a relatively good call. i've heard good calls in the past. bartz came on spitting out curse words and change ling. we heard a lot of the same things. focus, reorganizing the companies, but he's been very aggressive in a very short time frame. with regards to the asian assets he made it pretty clear that it may happen with a year term. the yahoo! japan stake make take a little longer to monetize. there seems to be negotiations with that. again, another good thing is he made it pretty clear that any monies to come in through that transaction would probably go directly to shareholders instead of going to some unwise big transaction. >> darren, are you supportive of the dan low proxy against the board? >> we are. we thing there's really no good reason not to support that investment. yeah, we are big fans of that slate, and we intent to vote for them. >> darren, right before you go, tell me what you made of this, display add revenue, decreased 4%. search up 8%. does that say anything about the larger advertising market or the health of the economy? >> no. unfortunately yahoo! hasn't been the growth of the economy or digital economy for quite some time. they're struggling, versus their main competitors, but the key issue forus or one of the things that we've seen in the recent quarter, recent months actually has been some deterioration in the search business, so we'd like to see that begin to stabilize. obviously they outsourced that operation to microsoft some time and they need to get that house back in order. it's a key cap flow generator for the kpaechl but i would, again, aur that it lies within there. so the core business is relevant and i like what thompson said last night but it doesn't necessarily have much to do with the stock price of yahoo. >> okay. we're going to keep an eye on that. darren, thanks. >> thank you. >> "financial times," where you wouldn't necessarily expect it. outrage about what's happening in argentina. >> you're back on argentina. >> the mexican president -- it's an elite story. the mexican authorities called it lamentable and said